AVALON GLOBOCARE CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2728 USD | -2.57% |
|
-10.70% | -43.52% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 200.9 | 146.2 | 91.17 | 72.49 | 51.72 | 5.313 |
| Enterprise Value (EV) 1 | 199.6 | 148.7 | 94.17 | 74.98 | 54.31 | 13.53 |
| P/E ratio | -25.5 x | -8.02 x | -7.02 x | -7.66 x | -4.07 x | -0.3 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 133 x | 98.1 x | 68.7 x | 54.5 x | 44.6 x | -0.72 x |
| EV / Revenue | 132 x | 99.7 x | 71 x | 56.4 x | 46.8 x | -1.85 x |
| EV / EBITDA | -27.9 x | -8.3 x | -7.72 x | -8.74 x | -7.59 x | -0.87 x |
| EV / FCF | -37.9 x | 362 x | -44.4 x | -42.9 x | -29.4 x | -1.76 x |
| FCF Yield | -2.64% | 0.28% | -2.25% | -2.33% | -3.4% | -56.8% |
| Price to Book | 16.6 x | 32.9 x | 22.4 x | 23.5 x | 24 x | -0.42 x |
| Nbr of stocks (in thousands) | 7,304 | 7,577 | 8,140 | 8,840 | 9,946 | 11,000 |
| Reference price 2 | 27.50 | 19.30 | 11.20 | 8.200 | 5.200 | 0.4830 |
| Announcement Date | 3/26/19 | 4/6/20 | 3/30/21 | 3/30/22 | 3/30/23 | 4/15/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1.509 | 1.491 | 1.326 | 1.331 | 1.16 | -7.334 |
| EBITDA 1 | -7.161 | -17.92 | -12.19 | -8.583 | -7.154 | -15.56 |
| EBIT 1 | -7.684 | -18.42 | -12.51 | -8.894 | -7.485 | -15.77 |
| Operating Margin | -509.11% | -1,236% | -943.05% | -668.49% | -645.07% | 215.05% |
| Earnings before Tax (EBT) 1 | -8.052 | -18.07 | -12.68 | -9.09 | -11.93 | -16.71 |
| Net income 1 | -7.774 | -18.07 | -12.68 | -9.09 | -11.93 | -16.71 |
| Net margin | -515.08% | -1,212.33% | -956.15% | -683.23% | -1,028.25% | 227.8% |
| EPS 2 | -1.080 | -2.406 | -1.595 | -1.071 | -1.279 | -1.587 |
| Free Cash Flow 1 | -5.267 | 0.4104 | -2.122 | -1.747 | -1.844 | -7.691 |
| FCF margin | -348.97% | 27.53% | -160.02% | -131.29% | -158.95% | 104.87% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/26/19 | 4/6/20 | 3/30/21 | 3/30/22 | 3/30/23 | 4/15/24 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | 2.43 | 3.01 | 2.49 | 2.58 | 8.22 |
| Net Cash position 1 | 1.25 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | -0.1354 x | -0.2466 x | -0.2901 x | -0.3611 x | -0.5283 x |
| Free Cash Flow 1 | -5.27 | 0.41 | -2.12 | -1.75 | -1.84 | -7.69 |
| ROE (net income / shareholders' equity) | -86.8% | -230% | -295% | -252% | -168% | -180% |
| ROA (Net income/ Total Assets) | -36.9% | -96.4% | -74.9% | -53.9% | -31.2% | -48.9% |
| Assets 1 | 21.1 | 18.74 | 16.92 | 16.85 | 38.25 | 34.18 |
| Book Value Per Share 2 | 1.650 | 0.5900 | 0.5000 | 0.3500 | 0.2200 | -1.150 |
| Cash Flow per Share 2 | 0.3100 | 0.1000 | 0.0900 | 0.0900 | 0.2000 | 0.0300 |
| Capex | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - |
| Announcement Date | 3/26/19 | 4/6/20 | 3/30/21 | 3/30/22 | 3/30/23 | 4/15/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -43.52% | 3.03M | |
| -17.89% | 8.25B | |
| +39.20% | 3.57B | |
| -39.11% | 2.46B | |
| -8.06% | 2.46B | |
| -7.35% | 2.38B | |
| -12.61% | 1.81B | |
| -19.01% | 1.55B | |
| -40.66% | 1.21B | |
| +7.56% | 1.11B |
- Stock Market
- Equities
- ALBT Stock
- Financials Avalon GloboCare Corp.
